This information was published on 2021-09-02T07:19:02 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2205572 (IR 1609773) |
| (220) |
27 Jul 2021
|
| (300) |
KR, 09 Mar 2021, 4020210047516
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceuticals; medicines for human purposes; anti-cancer preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer. |
| (540) |
|
| (730) |
APROGEN INC.
|
Find out more about publications on the About page.